Oxidative and carbonyl stress in patients with obstructive sleep apnea treated with continuous positive airway pressure

Sleep and Breathing

Volumn 16, Issue 2, 2012, Pages 393-398

  Celec, Peter ^a   Hodosy, Július ^a   Behuliak, Michal ^a   Pálffy, Roland ^a   Gardlík, Roman ^a   Halčák, Lukáč ^a   Mucska, Imrich ^b  

^a Physics and Informatics   (Slovakia)

^b UNIVERSITY HOSPITAL BRATISLAVA   (Slovakia)

Author keywords

Advanced glycation; Carbonyl stress; Oxidative stress; Salivary malondialdehyde; Sleep apnea

Indexed keywords

ADVANCED GLYCATION END PRODUCT; FERROUS ION; FRUCTOSAMINE; THIOBARBITURIC ACID;

ADULT; ARTICLE; BLOOD ANALYSIS; CARBONYL STRESS; FEMALE; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PLASMA; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SALIVA ANALYSIS; SLEEP APNEA SYNDROME;

ADULT; AGED; ANTIOXIDANTS; BIOLOGICAL MARKERS; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; FOLLOW-UP STUDIES; FRUCTOSAMINE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; POLYSOMNOGRAPHY; REFERENCE VALUES; SALIVA; SLEEP APNEA, OBSTRUCTIVE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TREATMENT OUTCOME;

EID: 84861481726     PISSN: 15209512     EISSN: 15221709     Source Type: Journal    
DOI: 10.1007/s11325-011-0510-4     Document Type: Article

References (34)

1. Jurkovicova I, Celec P (2004) Sleep apnea syndrome and its complications. Acta Med Austriaca 31:45-50 (Pubitemid 38703474)
2. Lavie L, Lavie P (2009) Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link. Eur Respir J 33:1467-1484
3. Miyata T, de Strihou CV, Kurokawa K, Baynes JW (1999) Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications. Kidney Int 55:389-399 (Pubitemid 29082866)
4. Streckfus CF, Bigler LR (2002) Saliva as a diagnostic fluid. Oral Dis 8:69-76 (Pubitemid 34298345)
5. Celec P, Hodosy J, Celecova V, Vodrazka J, Cervenka T, Halcak L, Bozek P, Kopani M, Kudela M (2005) Salivary thiobarbituric acid reacting substances and malondialdehyde - their relationship to reported smoking and to parodontal status described by the papillary bleeding index. Dis Markers 21:133-137 (Pubitemid 41566731)
6. Becker HF, Jerrentrup A, Ploch T, Grote L, Penzel T, Sullivan CE, Peter JH (2003) Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 107:68-73 (Pubitemid 36070935)
7. Kaneko Y, Floras JS, Usui K, Plante J, Tkacova R, Kubo T, Ando S, Bradley TD (2003) Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 348:1233-1241 (Pubitemid 36359299)
8. Marin JM, Carrizo SJ, Vicente E, Agusti AGN (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365:1046-1053 (Pubitemid 40386782)
9. Murri M, Alcazar-Ramirez J, Garrido-Sanchez L, Linde F, Alcaide J, Cardona F, Tinahones FJ (2009) Oxidative stress and metabolic changes after continuous positive airway pressure treatment according to previous metabolic disorders in sleep apnea-hypopnea syndrome patients. Transl Res 154:111-121
10. Christou K, Kostikas K, Pastaka C, Tanou K, Antoniadou I, Gourgoulianis KI (2009) Nasal continuous positive airway pressure treatment reduces systemic oxidative stress in patients with severe obstructive sleep apnea syndrome. Sleep Med 10:87-94
11. Carpagnano GE, Kharitonov SA, Resta O, Foschino-Barbaro MP, Gramiccioni E, Barnes PJ (2003) 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest 124:1386-1392 (Pubitemid 37290049)
12. Moser D, Anderer P, Gruber G, Parapatics S, Loretz E, Boeck M, Kloesch G, Heller E, Schmidt A, Danker-Hopfe H, Saletu B, Zeitlhofer J, Dorffner G (2009) Sleep classification according to AASM and Rechtschaffen & Kales: effects on sleep scoring parameters. Sleep 32:139-149
13. Hodosy J, Celec P (2005) Daytime of sampling, tooth-brushing and ascorbic acid influence salivary thiobarbituric acid reacting substances - a potential clinical marker of gingival status. Dis Markers 21:203-207 (Pubitemid 43074404)
14. Ohkawa H, Ohishi N, Yagi K (1978) Reaction of linoleic acid hydroperoxide with thiobarbituric acid. J Lipid Res 19:1053-1057 (Pubitemid 9059818)
15. Witko-Sarsat V, Friedlander M, CapeillereBlandin C, NguyenKhoa T, Nguyen NT, Zingraff J, Jungers P, DescampsLatscha B (1996) Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49:1304-1313 (Pubitemid 26166404)
16. Munch G, Keis R, Wessels A, Riederer P, Bahner U, Heidland A, Niwa T, Lemke HD, Schinzel R (1997) Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA. Eur J Clin Chem Clin Biochem 35:669-677
17. San-Gil F, Schier GM, Moses RG, Gan IE (1985) Improved estimation of fructosamine, as a measure of glycated serum protein, with the Technicon RA-1000 analyzer. Clin Chem 31:2005-2006 (Pubitemid 16052437)
18. Erel O (2004) A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 37:277-285
19. Benzie IFF, Strain JJ (1996) The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem 239:70-76
20. Dikmenoglu N, Ciftci B, Ileri E, Guven SF, Seringec N, Aksoy Y, Ercil D (2006) Erythrocyte deformability, plasma viscosity and oxidative status in patients with severe obstructive sleep apnea syndrome. Sleep Med 7:255-261
21. Jordan W, Cohrs S, Degner D, Meier A, Rodenbeck A, Mayer G, Pilz J, Ruther E, Kornhuber J, Bleich S (2006) Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome. J Neural Transm 113:239-254 (Pubitemid 43121759)
22. Selmi C, Montano N, Furlan R, Keen CL, Gershwin ME (2007) Inflammation and oxidative stress in obstructive sleep apnea syndrome. Exp Biol Med 232:1409-1413 (Pubitemid 350220538)
23. Ozkan Y, Firat H, Simsek B, Torun M, Yardim-Akaydin S (2008) Circulating nitric oxide (NO), asymmetric dimethylarginine (ADMA), homocysteine, and oxidative status in obstructive sleep apnea-hypopnea syndrome (OSAHS). Sleep Breath 12:149-154 (Pubitemid 351486675)
24. Ryan S, Taylor CT, McNicholas WT (2005) Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112:2660-2667 (Pubitemid 41532603)
25. Greenberg H, Ye XB, Wilson D, Htoo AK, Hendersen T, Liu SF (2006) Chronic intermittent hypoxia activates nuclear factor-kappa B in cardiovascular tissues in vivo. Biochem Biophys Res Commun 343:591-596
26. Suzuki YJ, Jain V, Park AM, Day RM (2006) Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases. Free Radic Biol Med 40:1683-1692 (Pubitemid 44308121)
27. Yamauchi M, Kimura H (2008) Oxidative stress in obstructive sleep apnea: putative pathways to the cardiovascular complications. Antioxid Redox Signal 10:755-768 (Pubitemid 351225902)
28. Lykkesfeldt J (2007) Malondialdehyde as biomarker of oxidative damage to lipids caused by smoking. Clin Chim Acta 380:50-58
29. WitkoSarsat V, Friedlander M, CapeillereBlandin C, NguyenKhoa T, Nguyen NT, Zingraff J, Jungers P, DescampsLatscha B (1996) Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49:1304-1313
30. Capeillere-Blandin C, Gausson V, Descamps-Latscha B, Witko-Sarsat V (2004) Biochemical and spectrophotometric significance of advanced oxidized protein products. Biochim Biophys Acta Mol Basis Dis 1689:91-102 (Pubitemid 38766144)
31. Hernandez C, Abreu J, Abreu P, Colino R, Jimenez A (2006) Effects of nasal positive airway pressure treatment on oxidative stress in patients with sleep apnea-hypopnea syndrome. Arch Bronconeumol 42:125-129
32. Takahashi KI, Chin K, Nakamura H, Morita S, Sumi K, Oga T, Matsumoto H, Niimi A, Fukuhara S, Yodoi J, Mishima M (2008) Plasma thioredoxin, a novel oxidative stress marker, in patients with obstructive sleep apnea before and after nasal continuous positive airway pressure. Antioxid Redox Signal 10:715-726 (Pubitemid 351225903)
33. Lavie P, Lavie L (2009) Unexpected survival advantage in elderly people with moderate sleep apnoea. J Sleep Res 18:397-403
34. Grebe M, Eisele HJ, Weissmann N, Schaefer C, Tillmanns H, Seeger W, Schulz R (2006) Antioxidant vitamin C improves endothelial function in obstructive sleep apnea. Am J Respir Crit Care Med 173:897-901